United States · FDA National Drug Code directory
Erlotinib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72485-217_35e3a161-752e-4479-b27c-3dc8efd3ca9e
- Product NDC
- 72485-217
- Form
- TABLET, FILM COATED
- Composition / generic term
- Erlotinib hydrochloride
- Labeler
- Armas Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191106
- Source listing expiry
- 20261231
Source-listed ingredients
- ERLOTINIB HYDROCHLORIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 BOX (72485-217-30) / 30 TABLET, FILM COATED in 1 BOTTLE · 72485-217-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →